vTv Therapeutics Inc sell tamam
Start price
18.04.18
/
50%
€2.07
Target price
31.05.18
€1.08
Performance (%)
-7.83%
End price
31.05.18
€1.91
Summary
This prediction ended on 31.05.18 with a price of €1.91. With a performance of -7.83%, the SELL prediction for vTv Therapeutics Inc by tamam was down slightly. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| vTv Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% | 69.888% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% | 101.814% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% | 45.300% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% | 63.763% |
Comments by tamam for this prediction
In the thread vTv Therapeutics Inc diskutieren
vTv Therapeutics' azeliragon flunks late-stage Alzheimer's study
Bottom feeders have stampeded into fallen biotech vTv Therapeutics
(Vom Mitglied beendet)